Latest filing published 13 Jan 2020 for GlaxoSmithKline plc, €570.
Insider track record
V A Whyte: trading record in brief
This profile gathers the share dealings of V A Whyte in GlaxoSmithKline plc. In total, 4 filings cover trades dated from 10 October 2019 to 9 January 2020.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 13 January 2020 came the latest disclosure, a share grant for €570 in GlaxoSmithKline plc. Filings reach the RNS (LSE) feed a median of 3 days after the trade. The legal deadline for notifying a trade is three business days (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to V A Whyte
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 27 shares@ £17.90318.4% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20200113110138_14381536_20200331164951975_11111-3
- 49 shares@ £17.928433.4% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20200113103452_14381503_20200331164951972_11078-10
- 50 shares@ £17.184264.9% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20191011173441_14263837_20200326185154344_23268-9
- 27 shares@ £17.20335.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20191011161001_14263725_20200326185154351_23377-0
4 of 4 declarations